Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00574587
Title Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Montefiore Medical Center

Her2-receptor positive breast cancer


Paclitaxel + Vorinostat


Cyclophosphamide + Doxorubicin

Age Groups: adult
Covered Countries USA

No variant requirements are available.